Mode
Text Size
Log in / Sign up

Psychiatry

678 published articles · Updated continuously

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Children with ASD reported lower perceived navigation ability than typically developing peers in an observational study
Psychiatry
Children with ASD reported lower perceived navigation ability than typically developing peers in an observational study Autistic Kids Navigate Fine, But Feel Lost Inside
This observational study compared 26 children with high-functioning autism spectrum disorder (ASD) to 25 typically developing peers.
Autistic kids navigate just as well as peers, yet they often feel lost inside, revealing a gap between ability and confidence.
Deep brain stimulation of the anterior limb of the internal capsule reduced OCD symptoms in a small observational study
Psychiatry
Deep brain stimulation of the anterior limb of the internal capsule reduced OCD symptoms in a small observational study A Tiny Brain Signal May Show When OCD Treatment Is Working
This observational study evaluated deep brain stimulation (DBS) of the anterior limb of the internal capsule in 10 clinically responsive…
A drop in a specific brain wave signal may tell doctors when deep brain stimulation is finally easing severe obsessive-compulsive disorder s…
Meta-analysis shows psychotherapy effect sizes vary by baseline depression severity compared to control conditions
Psychiatry Meta-analysis
Meta-analysis shows psychotherapy effect sizes vary by baseline depression severity compared to control conditions Depression Treatment Works Best For The Most Severe Cases
This meta-analysis evaluated 47,315 patients with depression to assess how baseline severity influences treatment response.
Depression therapy works best for the most severe cases, with response rates improving as symptoms worsen, according to a large review of 38…
Omega-3 supplementation reduces stress, anxiety, and depression in Saudi adults over three months
Psychiatry RCT
Omega-3 supplementation reduces stress, anxiety, and depression in Saudi adults over three months Omega-3s Help Calm Stress And Improve Sleep
A randomized, double-blind, placebo-controlled trial in 64 Saudi adults found that omega-3 supplementation (500 mg EPA + 250 mg DHA) signifi…
A new trial shows omega-3 supplements significantly reduce stress, anxiety, and depression while improving sleep and memory in people with s…
Ten-week Baduanjin exercise improved sleep and mood in college students with Qi-deficiency constitution
Psychiatry RCT
Ten-week Baduanjin exercise improved sleep and mood in college students with Qi-deficiency constitution Could a gentle 10-week exercise routine help college students feel less anxious and sleep better?
This small randomized study enrolled 37 college students with Qi-deficiency constitution and sleep problems, assigning 18 to control and 19 …
Many college students struggle with sleep and anxiety, often feeling a sense of low energy or weakness.
Systematic review finds exercise prescription linked to mood, cognition, and stress resilience benefits
Psychiatry Sys. Review
Systematic review finds exercise prescription linked to mood, cognition, and stress resilience benefits Your Workout May Boost Mood Through Your Gut, Not Just Your Brain
A systematic review suggests exercise prescription is associated with advantageous impacts on mood, cognitive function, and stress resilienc…
Daily exercise may lift your mood by changing gut bacteria to produce mood-boosting molecules that signal your brain.
Internet-based CBT relapse predictors in remitted major depressive disorder patients
Psychiatry RCT
Internet-based CBT relapse predictors in remitted major depressive disorder patients For those who beat depression with online therapy, what risks relapse and how to stay well?
This secondary analysis of a randomized controlled trial examined relapse in 83 remitted patients with major depressive disorder over 12 mon…
After beating depression with online therapy, about one-third of people relapse within a year, but finishing the program and seeking care wh…
Zanubrutinib-combined therapy in heavily treated non-GCB DLBCL: retrospective two-center cohort of 27 patients
Psychiatry Cohort
Zanubrutinib-combined therapy in heavily treated non-GCB DLBCL: retrospective two-center cohort of 27 patients New hope for tough lymphoma cases
A retrospective two-center cohort of 27 heavily treated patients with relapsed/refractory non-GCB DLBCL evaluated zanubrutinib-combined ther…
Combining zanubrutinib with other treatments helped 74% of patients with tough, hard-to-treat lymphoma respond after standard options failed…
Immuno-kynurenine shifts track cognitive change in antipsychotic-naive first-episode schizophrenia
Psychiatry Guideline
Immuno-kynurenine shifts track cognitive change in antipsychotic-naive first-episode schizophrenia New Brain Signals Show Why Early Treatment Works
A longitudinal observational study of antipsychotic-naive first-episode schizophrenia patients and healthy controls examined peripheral infl…
Early treatment for schizophrenia clears thinking fog by fixing brain chemistry and immune signals that cause mental confusion before scary …
Medically supervised ketogenic diet shows preliminary efficacy for moderate to severe major depressive disorder in a pilot trial
Psychiatry
Medically supervised ketogenic diet shows preliminary efficacy for moderate to severe major depressive disorder in a pilot trial Ketogenic Diet May Ease Severe Depression
This open-label, single-arm pilot feasibility trial evaluated a medically supervised ketogenic diet (MSKD) in 11 individuals with moderate t…
A low-carb, high-fat diet helped most participants maintain ketosis and showed promise for treating moderate to severe depression in a new p…
FDA Approves Concerta (methylphenidate) for ADHD in Patients Aged 6 to 65 Years
Psychiatry FDA Approval
FDA Approves Concerta (methylphenidate) for ADHD in Patients Aged 6 to 65 Years The FDA approved a new once-daily ADHD medication called Concerta for people ages 6 to 65
Concerta (methylphenidate) is approved for the treatment of attention deficit hyperactivity disorder (ADHD) in patients aged 6 to 65 years.
The FDA approved Concerta, a once-daily ADHD medication, for people ages 6 to 65 to help manage symptoms throughout the day with a single do…
Prochlorperazine Labeling: Indicated for Severe Nausea/Vomiting and Schizophrenia
Psychiatry FDA Approval
Prochlorperazine Labeling: Indicated for Severe Nausea/Vomiting and Schizophrenia The FDA approved a new injection to treat severe nausea and schizophrenia when pills cannot be taken
FDA labeling for prochlorperazine lists two approved indications: control of severe nausea and vomiting and treatment of schizophrenia.
A new FDA-approved injection now treats severe nausea and schizophrenia when patients cannot take pills by mouth.